Skip to main content

Published locations for High-dose methotrexate does not reduce CNS progression risk in high-risk aggressive BCL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. High-dose methotrexate does not reduce CNS progression risk in high-risk aggressive BCL

User login

  • Reset your password
  • /content/high-dose-methotrexate-does-not-reduce-cns-progression-risk-high-risk-aggressive-bcl
  • /b-cell-lymphoma-icymi/article/266056/b-cell-lymphoma/high-dose-methotrexate-does-not-reduce-cns